UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000037425 |
|---|---|
| Receipt number | R000042420 |
| Scientific Title | Biomarker sub study of the phase II study of trastuzumab and pertuzumab combination therapy for HER2 amplified advanced solid tumors |
| Date of disclosure of the study information | 2019/08/01 |
| Last modified on | 2023/01/20 11:28:36 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2019/07/19 10:06:42 | ||
| 2 | Update | 2019/12/06 09:29:28 | Recruitment status Date of IRB |
|
| 3 | Update | 2020/04/02 18:13:44 | Division name |
|
| 4 | Update | 2020/07/08 11:38:44 | Recruitment status |
|
| 5 | Update | 2022/07/21 10:14:00 | Last follow-up date |
|
| 6 | Update | 2023/01/20 11:28:36 | Email |
